Table 3.

HLA class II typing of donors and ESRD patients.

	Related donor			Unrelated donor
	Donor (N = 252)*	Recipient (N = 252)*	P value	Donor (N = 216)*	Recipient (N = 196)*	P value
HLA-DRB1
1	1 (0.4)	1 (0.4)	1.000	1 (0.5)	0 (0.0)	–
3	12 (4.8)	9 (3.6)	.505	14 (6.5)	6 (3.1)	.115
4	27 (10.7)	32 (12.7)	.489	18 (8.3)	22 (11.2)	.324
7	13 (5.2)	8 (3.2)	.270	14 (6.5)	8 (4.1)	.283
8	8 (3.2)	9 (3.6)	.805	7 (3.2)	9 (4.6)	.481
9	30 (11.9)	31 (12.3)	.891	26 (12.0)	19 (9.7)	.447
10	22 (8.7)	25 (9.9)	.646	14 (6.5)	15 (7.7)	.643
11	5 (2.0)	10 (4.0)	.199	3 (1.4)	8 (4.1)	.106
12	73 (29.0)	84 (33.3)	.290	59 (27.3)	69 (35.2)	.085
13	11 (4.4)	6 (2.4)	.224	12 (5.6)	4 (2.0)	.077
14	13 (5.2)	9 (3.6)	.386	16 (7.4)	13 (6.6)	.759
15	33 (13.1)	25 (9.9)	.265	24 (11.1)	19 (9.7)	.639
16	4 (1.6)	3 (1.2)	.704	8 (3.7)	3 (1.5)	.186
18				0 (0.0)	1 (0.5)	–
HLA-DQA1
1	86 (34.1)	80 (31.7)	.570	82 (38.0)	64 (32.7)	.261
2	13 (5.2)	8 (3.2)	.270	14 (6.5)	7 (3.6)	.186
3	56 (22.2)	60 (23.8)	.672	41 (19.0)	40 (20.4)	.716
4	12 (4.8)	19 (7.5)	.198	8 (3.7)	8 (4.1)	.843
5	25 (9.9)	22 (8.7)	.646	25 (11.6)	17 (8.7)	.333
6	60 (23.8)	63 (25.0)	.756	46 (21.3)	60 (30.6)	.031
HLA-DQB1
1	0 (0.0)	3 (1.2)	–	1 (0.5)	0 (0.0)	–
2	16 (6.3)	15 (6.0)	.853	27 (12.5)	9 (4.6)	.006
3	135 (53.6)	145 (57.5)	.370	100 (46.3)	111 (56.6)	.036
4	15 (6.0)	17 (6.7)	.715	9 (4.2)	12 (6.1)	.370
5	67 (26.6)	58 (23.0)	.354	62 (28.7)	43 (21.9)	.116
6	19 (7.5)	14 (5.6)	.370	17 (7.9)	21 (10.7)	.321

Bold values indicate statistical significance.

ESRD = end-stage renal disease, HLA = human leukocyte antigen.

^*Number of alleles.